Public 'bickering' between Downing Street and NHS England chief Simon Stevens is damaging an NHS already at risk of “catastrophic failure”, according to a new parli
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh